Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M402270200 on May 13, 2004 Originally published In Press as doi:10.1074/jbc.M402270200 on May 7, 2004

J. Biol. Chem., Vol. 279, Issue 38, 39671-39676, September 17, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/38/39671    most recent
M402270200v2
M402270200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beringue, V.
Right arrow Articles by Hawke, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beringue, V.
Right arrow Articles by Hawke, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

PrPSc Binding Antibodies Are Potent Inhibitors of Prion Replication in Cell Lines*

Vincent Beringue{ddagger}§, Didier Vilette§, Gary Mallinson{ddagger}||, Fabienne Archer§, Maria Kaisar{ddagger}||, Mourad Tayebi{ddagger}||, Graham S. Jackson||, Anthony R. Clarke||, Hubert Laude§, John Collinge||, and Simon Hawke{ddagger}||**

From the {ddagger}Department of Neurogenetics, CNS Infection and Immunity Group, Faculty of Medicine, Imperial College, London W2 1PG, United Kingdom, §Unité de Virologie et Immunologie Moléculaires, Institut National de la Recherche Agronomique, 78 352 Jouy en Josas, France, and ||Medical Research Council, Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom

Conversion of the cellular {alpha}-helical prion protein (PrPC) into a disease-associated isoform (PrPSc) is central to the pathogenesis of prion diseases. Molecules targeting either normal or disease-associated isoforms may be of therapeutic interest, and the antibodies binding PrPC have been shown to inhibit prion accumulation in vitro. Here we investigate whether antibodies that additionally target disease-associated isoforms such as PrPSc inhibit prion replication in ovine PrP-inducible scrapie-infected Rov cells. We conclude from these experiments that antibodies exclusively binding PrPC were relatively inefficient inhibitors of ScRov cell PrPSc accumulation compared with antibodies that additionally targeted disease-associated PrP isoforms. Although the mechanism by which these monoclonal antibodies inhibit prion replication is unclear, some of the data suggest that antibodies might actively increase PrPSc turnover. Thus antibodies that bind to both normal and disease-associated isoforms represent very promising anti-prion agents.


Received for publication, March 1, 2004 , and in revised form, May 6, 2004.

* This work was supported by grants from the Medical Research Council (London, United Kingdom) and by a Marie Curie Fellowship grant from the European Union. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Present address: UMR754 Rétrovirus et Pathologie Comparée, Institut National de la Recherche Agronomique, 69 366 Lyon, France.

** Present address. To whom correspondence should be addressed: Brain and Mind Research Institute, University of Sydney, New South Wales 2006, Australia. Tel.: 61263620711; Fax: 61263620129; E-mail: s.hawke{at}imperial.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
M. Dron, F. Dandoy-Dron, M. K. Farooq Salamat, and H. Laude
Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells
J. Gen. Virol., August 1, 2009; 90(8): 2050 - 2060.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Tayebi, J. Collinge, and S. Hawke
Unswitched immunoglobulin M response prolongs mouse survival in prion disease
J. Gen. Virol., March 1, 2009; 90(3): 777 - 782.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. V. Antonyuk, C. R. Trevitt, R. W. Strange, G. S. Jackson, D. Sangar, M. Batchelor, S. Cooper, C. Fraser, S. Jones, T. Georgiou, et al.
Crystal structure of human prion protein bound to a therapeutic antibody
PNAS, February 24, 2009; 106(8): 2554 - 2558.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Sacquin, A. S. Bergot, P. Aucouturier, and M. Bruley-Rosset
Contribution of Antibody and T Cell-Specific Responses to the Progression of 139A-Scrapie in C57BL/6 Mice Immunized with Prion Protein Peptides
J. Immunol., July 1, 2008; 181(1): 768 - 775.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. R Trevitt and J. Collinge
A systematic review of prion therapeutics in experimental models
Brain, September 1, 2006; 129(9): 2241 - 2265.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gregoire, A. S. Bergot, C. Feraudet, C. Carnaud, P. Aucouturier, and M. B. Rosset
The Murine B Cell Repertoire Is Severely Selected against Endogenous Cellular Prion Protein
J. Immunol., November 15, 2005; 175(10): 6443 - 6449.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Feraudet, N. Morel, S. Simon, H. Volland, Y. Frobert, C. Creminon, D. Vilette, S. Lehmann, and J. Grassi
Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells
J. Biol. Chem., March 25, 2005; 280(12): 11247 - 11258.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement